Influence of the stage of emergency declaration due to the coronavirus disease 2019 outbreak on plasma glucose control of patients with diabetes mellitus in the Saku region of Japan

DOI Web Site 被引用文献2件 参考文献4件
  • Watanabe Takuya
    Department of Endocrinology and Metabolism, Saku Central Hospital Advanced Care Center, Japan
  • Temma Yuichi
    Department of Endocrinology and Metabolism, Saku Central Hospital Advanced Care Center, Japan
  • Okada Junichi
    Department of Medicine, Division of Endocrinology, Albert Einstein College of Medicine, USA
  • Yamada Eijiro
    Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
  • Saito Tsugumichi
    Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
  • Okada Kazuya
    Omagari Kosei Medical Center, Japan
  • Nakajima Yasuyo
    Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
  • Ozawa Atsushi
    Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
  • Takamizawa Tetsuya
    Department of Endocrinology and Metabolism, Saku Central Hospital Advanced Care Center, Japan
  • Horigome Mitsuaki
    Department of Endocrinology and Metabolism, Saku Central Hospital Advanced Care Center, Japan
  • Okada Shuichi
    Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
  • Yamada Masanobu
    Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan

この論文をさがす

抄録

<p>Objective: Because patients with diabetes mellitus (DM) were forced to stay indoors during the state of emergency, resulting in stress and a lack of physical activity, concerns about their glycemic control were raised.</p><p>Patients and Methods: The 165 patients’ glycated hemoglobin (HbA1c) levels were compared during the following periods: the 4 months that were selected as a representative condition 1 year before the COVID-19 pandemic (May 2018, March 2019, June 2019, and July 2019) and the latter 3 months as a 1-year follow-up during the COVID-19 pandemic (May 2019, March 2020, June 2020, and July 2020).</p><p>Results: The patients’ HbA1c levels were 7.32 ± 1.23, 7.44 ± 1.20, 7.16 ± 1.06, 7.01 ± 1.05, 7.23 ± 1.06, 7.45 ± 1.18, 7.15 ± 10.7, and 7.11 ± 1.17 in May 2018, March 2019, June 2019, July 2019, May 2019, March 2020, June 2020, and July 2020, respectively (expressed as mean ± standard deviation).</p><p>Conclusion: The analysis showed that HbA1c levels did not worsen during the self-restraint period.</p>

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (4)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ